Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 4 | 44 | 170 | 33 |
| Receivables | 0 | 0 | N/A | 50 | N/A |
| TOTAL | $1 | $4 | $44 | $220 | $33 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1 | $4 | $44 | $220 | $33 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 488 | 299 | 162 | 168 | 92 |
| Other current liabilities | N/A | N/A | N/A | N/A | 532 |
| TOTAL | $2,093 | $1,904 | $1,881 | $1,019 | $1,214 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,093 | $1,904 | $1,881 | $1,019 | $1,214 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,188 | 97,035 | 97,032 | 88,026 | 86,476 |
| Common Shares | 97 | 97 | 88 | 87 | 85 |
| Retained earnings | -3,912 | -3,710 | -2,782 | -2,241 | -1,579 |
| TOTAL | $-2,093 | $-1,900 | $-1,837 | $-799 | $-1,181 |
| Total Liabilities And Equity | $1 | $4 | $44 | $220 | $33 |